US Patent

US10413543 — Stable multiparticulate pharmaceutical composition of rosuvastatin

Formulation · Assigned to Sun Pharma Advanced Research Co Ltd · Expires 2036-02-12 · 10y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a stable multi-particulate pharmaceutical composition of rosuvastatin that includes pellets with specific ingredients.

USPTO Abstract

A stable multi-particulate pharmaceutical composition comprising pellets, the pellets comprising a mixture of rosuvastatin or its pharmaceutically acceptable salts as a sole active ingredient, one or more osmotic release modifiers and one or more stabilizers.

Drugs covered by this patent

Patent Metadata

Patent number
US10413543
Jurisdiction
US
Classification
Formulation
Expires
2036-02-12
Drug substance claim
No
Drug product claim
Yes
Assignee
Sun Pharma Advanced Research Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.